Research Tools
Comparisons
Screeners
Smart Portfolio
My Watchlist
Profile & Performance
Top Experts
News
Calendars
Calendars & Events
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock ComparisonAirline StocksBank StocksBiotech StocksBitcoin StocksCannabis StocksCasino StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksElectric Vehicles StocksFAANG StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksStay-At-Home StocksWallStreetBets StocksWork-From-Home Stocks
Compare the best Biotech stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Comparison Results
Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
VRTXVertex Pharmaceuticals
$201.33
$262.36
(30.31% Upside)
$52.23B
26.10
-27.44%
19Buy
5Hold
1Sell
Moderate Buy
Performance Comparison
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Recent Analysts Ratings of Biotech Stocks
Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
Most Recent Earnings of Biotech Stocks
SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Biotech Stocks - FAQ
Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Biotech stocks overpriced?
Gilead Sciences's stock price is currently $69.47, and its average 12-month price target is $79.57.
Amgen's stock price is currently $235.45, and its average 12-month price target is $227.45.
Vertex Pharmaceuticals's stock price is currently $201.33, and its average 12-month price target is $262.36.
Biogen's stock price is currently $339.00, and its average 12-month price target is $433.38.
Illumina's stock price is currently $501.98, and its average 12-month price target is $442.50.
Which Biotech stocks pay dividends?
Gilead Sciences currently pays a dividend of $0.71 which represents an annual dividend yield of 4.02%. Gilead Sciences's next Ex-dividend date is September 14, 2021 and its next payout date is September 29, 2021.
Amgen currently pays a dividend of $1.76 which represents an annual dividend yield of 2.71%. Amgen's next Ex-dividend date is August 16, 2021 and its next payout date is September 8, 2021.
Vertex Pharmaceuticals does not currently pay dividends.
Biogen does not currently pay dividends.
Illumina does not currently pay dividends.
Popular Stock Comparisons
5g StocksAirline StocksBank StocksBiotech StocksBitcoin StocksCannabis StocksCasino StocksChinese StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksElectric Vehicles StocksFAANG StocksGold StocksGrowth StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksSolar StocksSpace StocksStay-At-Home StocksTech StocksVideo Game StocksWallStreetBets StocksWork-From-Home Stocks